Table 1 Clinicopathological characteristics of patients after propensity score matching
From: Feasibility analysis of combined surgery for esophageal cancer
Characteristic | SEC (N=174) | COEC (N=87) | P | SMD |
|---|---|---|---|---|
Age | 62.99±7.782 | 63.30±6.847 | 0.752 | 0.042 |
Sex | 0.391 | 0.111 | ||
Male | 140 (80.5%) | 66 (75.9%) | ||
Female | 34 (19.5%) | 21 (24.1%) | ||
BMI | 23.74±3.381 | 23.81±2.427 | 0.861 | 0.024 |
Smoking | 0.334 | 0.127 | ||
No | 91 (59.0%) | 51 (58.6%) | ||
Yes | 83 (41.0%) | 36 (41.4%) | ||
Drinking | 0.523 | 0.084 | ||
No | 119 (68.8%) | 58 (66.7%) | ||
Yes | 54 (31.2%) | 29 (33.3%) | ||
Lung disease | 0.270 | 0.150 | ||
No | 157 (90.2%) | 82 (94.3%) | ||
Yes | 17 (9.8%) | 5 (5.7%) | ||
Diabetes | 0.781 | 0.037 | ||
No | 154 (88.5%) | 78 (89.7%) | ||
Yes | 20 (11.5%) | 9 (10.3%) | ||
Hypertension | 1.000 | <0.001 | ||
No | 108 (632.1%) | 54 (62.1%) | ||
Yes | 66 (37.9%) | 33 (37.9%) | ||
Coronary heart disease | 1.000 | <0.001 | ||
No | 168 (96.6%) | 84 (96.6%) | ||
Yes | 6 (3.4%) | 3 (3.4%) | ||
Surgical history | 0.830 | 0.028 | ||
No | 138 (79.3%) | 68 (78.2%) | ||
Yes | 36 (20.7%) | 19 (21.8%) | ||
FVC | 3.63±0.750 | 3.58±0.717 | 0.614 | 0.067 |
FEV1 | 2.71±0.628 | 2.69±0.613 | 0.856 | 0.024 |
DLCO | 7.13±1.773 | 7.18±1.719 | 0.850 | 0.025 |
EF | 63.44±2.307 | 63.39±2.384 | 0.866 | 0.022 |
ALB | 40.37±3.515 | 39.99±4.200 | 0.450 | 0.096 |
Neoadjuvant therapy | 1.000 | <0.001 | ||
No | 118 (67.8%) | 59 (67.8%) | ||
Yes | 56 (32.2%) | 28 (32.2%) | ||
Surgical procedures | 0.898 | 0.017 | ||
McKeown | 151 (86.8%) | 75 (86.2%) | ||
Othersa | 23 (13.2%) | 12 (13.8%) | ||
Tumor location | 0.168 | 0.102 | ||
Upper | 33 (19.0%) | 10 (11.5%) | ||
Middle | 65 (37.4%) | 35 (40.2%) | ||
Lower | 65 (37.4%) | 40 (46.0%) | ||
GEJ | 11 (6.3%) | 2 (2.3%) | ||
Tumor size (cm) | 3.16±1.443 | 3.16±1.532 | 0.988 | 0.002 |
Histological type | 0.738 | 0.040 | ||
Squamous | 154 (88.5%) | 75 (86.2%) | ||
Adenocarcinoma | 15 (8.6%) | 10 (11.5%) | ||
Other | 5 (2.9%) | 2 (2.3%) | ||
TNM stage | 0.825 | 0.075 | ||
1 | 65 (37.4%) | 30 (34.5%) | ||
2 | 62 (35.6%) | 32 (36.8%) | ||
3 | 44 (25.3%) | 22 (25.3%) | ||
4 | 3 (1.7%) | 3 (3.4%) |